We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pfizer Healthcare Ireland

9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Patient Information Leaflet last updated on medicines.ie: 04/09/2014
PIL Revatio 20 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 04/09/2014 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to MA holder contact details
Updated on 30/06/2014 and displayed until 04/09/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 24/01/2014 and displayed until 30/06/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 24/12/2013 and displayed until 24/01/2014
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/10/2013 and displayed until 24/12/2013
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 28/08/2013 and displayed until 22/10/2013
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Improved electronic presentation
Updated on 23/04/2013 and displayed until 28/08/2013
Reasons for adding or updating:
  • Change to date of revision
Updated on 21/01/2013 and displayed until 23/04/2013
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/08/2012 and displayed until 21/01/2013
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 03/07/2012 and displayed until 07/08/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change to improve clarity and readability
Updated on 27/03/2012 and displayed until 03/07/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 17/01/2012 and displayed until 27/03/2012
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 04/11/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
  • Change to MA holder contact details
Updated on 13/07/2011 and displayed until 04/11/2011
Reasons for adding or updating:
  • PIL re-instated
Updated on 13/05/2011 and displayed until 13/07/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to date of revision
  • PIL Submitted in error
Updated on 04/04/2011 and displayed until 13/05/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 27/01/2011 and displayed until 04/04/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to MA holder contact details
Updated on 13/10/2010 and displayed until 27/01/2011
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
Updated on 12/01/2010 and displayed until 13/10/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/02/2009 and displayed until 12/01/2010
Reasons for adding or updating:
  • Addition of marketing authorisation holder
Updated on 15/10/2008 and displayed until 23/02/2009
Reasons for adding or updating:
  • Change to further information section
Updated on 01/04/2008 and displayed until 15/10/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/09/2007 and displayed until 01/04/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to further information section
  • Correction of spelling/typing errors
Updated on 24/08/2007 and displayed until 10/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 13/04/2007 and displayed until 24/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 24/01/2007 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/11/2006 and displayed until 24/01/2007
Reasons for adding or updating:
  • Change to further information section
Updated on 25/09/2006 and displayed until 14/11/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/09/2006 and displayed until 25/09/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 01/08/2006 and displayed until 05/09/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   sildenafil citrate